Javier Martínez‐Sanz

Author

Instituto Ramón y Cajal de Investigación Sanitaria ORCID

Also Known As

Alejandro de Gea Grela, J Martinez-Lacasa, J Martínez-Lacasa, J Santos, J Sanz, J. M. Sanz, J. Martinez-Lacasa, J. Martínez-Lacasa, J. Martínez-Sanz, J. Martínez‐Lacasa

172

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Instituto Ramón y Cajal de Investigación Sanitaria Hospital Universitario Ramón y Cajal Universidad de Alcalá Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Centro de Investigación Biomédica en Red

About

Javier Martínez‐Sanz is an author at Instituto Ramón y Cajal de Investigación Sanitaria specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	10	420
2	Epidemiology	7	9	404
3	Public Health	6	6	200
4	Social Sciences	1	1	13
5	Geography	1	1	16

Javier Martínez‐Sanz

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study) Daniel Podzamczer, Elena Ferrer, Ezequiel Consiglio, Antiviral Therapy	2002	137
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine Daniel Podzamczer, Elena Ferrer, Pochita Sanchez, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	136
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study Javier Martínez‐Sanz, Alfonso Muriel, Raquel Ron, Clinical Microbiology and Infection Long CovidMedicineMulticentre Cohort StudyCovid-19 PandemicClinical Epidemiology	2020	108
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study Sergio Serrano‐Villar, Alba Talavera-Rodríguez, María José Gosalbes, Nature Communications	2021	90
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron, The Lancet HIV Primary ImmunodeficiencyTreatment And PreventionHuman RetrovirusImmunologyFirst-line Antiretroviral Therapy	2020	68
CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring? Raquel Ron, Elena Moreno, Javier Martínez‐Sanz, Clinical Infectious Diseases	2023	59
Population-Based Pragmatic Trial of Advance Care Planning in Primary Care in the University of California Health System Anne M. Walling, Rebecca L. Sudore, Chi‐Hong Tseng, Journal of Palliative Medicine	2019	40
Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia A.M. López Martos, Daniel Podzamczer, Javier Martínez‐Sanz, AIDS	1995	38
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events Javier Martínez‐Sanz, Jorge Díaz-Álvarez, Marta Rosas Cancio-Suárez, EBioMedicine	2023	32
Impact of a structured HIV testing program in a hospital emergency department and a primary care center Cristina Gómez‐Ayerbe, Javier Martínez‐Sanz, Alfonso Muriel, PLoS ONE	2019	31

Page 1